21,744 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Acquired by Bank OZK

Bank OZK acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 21,744 shares of the company's stock, valued at approximately $1,700,000.

Other large investors have also recently made changes to their positions in the company. State Street Corp lifted its holdings in GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after buying an additional 1,347,114 shares during the last quarter. Geode Capital Management LLC lifted its stake in GE HealthCare Technologies by 7.2% during the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock worth $1,026,898,000 after purchasing an additional 733,819 shares during the last quarter. Van ECK Associates Corp boosted its holdings in GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after purchasing an additional 2,506,417 shares in the last quarter. Bank of New York Mellon Corp increased its stake in GE HealthCare Technologies by 11.2% in the fourth quarter. Bank of New York Mellon Corp now owns 3,476,586 shares of the company's stock valued at $271,800,000 after purchasing an additional 349,539 shares during the last quarter. Finally, D1 Capital Partners L.P. acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $268,159,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on GEHC. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $97.67.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded up $0.45 on Wednesday, reaching $84.76. 3,086,799 shares of the stock were exchanged, compared to its average volume of 2,934,414. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $38.76 billion, a PE ratio of 19.58, a PEG ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The business has a fifty day moving average price of $86.41 and a two-hundred day moving average price of $86.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.